Pre-flight Evaluation of Adult Patients With Cystic Fibrosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01569880
Recruitment Status : Completed
First Posted : April 3, 2012
Last Update Posted : April 3, 2012
Information provided by (Responsible Party):
Oslo University Hospital

Brief Summary:
The purpose of the study is to investigate the relationship between hypoxemia achieved during Hypoxia Altitude Simulation test and sea level values of pulmonary function, arterial blood gases, pulse oximetry and cardiopulmonary exercise test variables. In addition, to study the effect of slow walk in a hypoxic environment, comparable to slow walking along the aisle.

Condition or disease
Cystic Fibrosis

Study Type : Observational
Actual Enrollment : 30 participants
Observational Model: Case-Only
Time Perspective: Prospective
Official Title: Pre-flight Evaluation of Adult Patients With Cystic Fibrosis
Study Start Date : January 2006
Primary Completion Date : December 2008
Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cystic Fibrosis
U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   17 Years to 80 Years   (Child, Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Adult patients with cystic fibrosis

Inclusion Criteria:

  • Cystic fibrosis
  • > 16 years
  • Sputum test negative for Burkholderia cepacia and/or methicillin resistant Staphylococcus aureus

Exclusion Criteria:

  • Ongoing infection

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT01569880

Oslo University Hospital, Ullevål
Oslo, Norway, 0450
Sponsors and Collaborators
Oslo University Hospital
Principal Investigator: Bjørn Skrede, PhD MD Oslo University Hospital

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Oslo University Hospital Identifier: NCT01569880     History of Changes
Other Study ID Numbers: CF-HAST-OUS
First Posted: April 3, 2012    Key Record Dates
Last Update Posted: April 3, 2012
Last Verified: March 2012

Keywords provided by Oslo University Hospital:
Blood gas response
Gas exchange
Hypoxia altitude simulation test
Pulmonary function

Additional relevant MeSH terms:
Cystic Fibrosis
Pathologic Processes
Pancreatic Diseases
Digestive System Diseases
Lung Diseases
Respiratory Tract Diseases
Genetic Diseases, Inborn
Infant, Newborn, Diseases